Extended Post Anaesthetic Care in PACU During COVID-19: Multi-perspective Value-based Analysis

Sponsor
Tuen Mun Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04717089
Collaborator
Anaesthesia & Operation Theatre Service, Tuen Mun Hospital, Hong Kong (Other), Intensive Care Unit, Tuen Mun Hospital, Hong Kong (Other)
299
1
16.6
18

Study Details

Study Description

Brief Summary

To evaluate the value-based effectiveness of the implementation of TMH Extended post anaesthetic care in PACU during COVID-19 pandemics by an institutional matched case-control and quantitative survey study Two ordinary recovery beds were converted to an overnight intensive recovery ("Extended post-anesthetic care in PACU") within the operating theatre complex of Tuen Mun Hospital during COVID-19 pandemics, in an attempt to free the ICU bed and resources from postoperative patients. This study was designed to evaluate the efficacy and staff perceptions towards the abrupt implementation of TMH extended post-anesthetic care in PACU by mobilization of the existing OT resources to cope with the COVID-19 emergency situations. The value-based analysis would look into the implementation effectiveness in twofold: 1) the clinical efficacy using a case-control audit on clinical outcomes and 2) the staff acceptance by means of the staff attitudes survey. Hopefully, this would provide a multi-perspective evaluation of the implementation strategies and aid planning of new services in the future.

Condition or Disease Intervention/Treatment Phase
  • Other: overnight intensive recovery / extended post anaesthetic care in PACU

Detailed Description

2 parts are included in this study

The Matched Case-Control study, with the aim of analyzing the clinical efficacy of TMH Extended post-anesthetic care in PACU during COVID-19 in a value-based healthcare model. We included all postoperative patients admitted in TMH Extended post-anesthetic care in PACU during COVID epidemics, excluding patients awaiting ICU in the ordinary recovery room or patients requiring level 3 intensive care on arrival in the recovery room. Three activation periods of 水xtended post-anesthetic care in PACU service (10 Feb - 26 Apr 2020 / 27 Jul - 13 Sep 2020 / 14 Dec 2020 - 28 Feb 2021), and performed case matching with the postoperative patient with similar clinical characteristics entering intensive care unit directly in recent 10 years, with each case matched with specifically 5 control. We evaluate the value-based health care efficacy, including the amount of healthcare expenditure based on bed occupancy and manpower, rate of elective discharge to intensive care unit from extended post-anesthetic care in PACU, rate of unanticipated intensive care admission within 48hrs upon discharge to the general ward, and length of hospital stay, and the total number of ICU bed spared.

The staff attitude survey, with the aim to investigate the staff perception towards the implementation of TMH extended post-anesthetic care in PACU during COVID-19 pandemics based on the Technology Acceptance Model in healthcare. We designed a questionnaire based on Technology Acceptance Model, and distributed it to medical and nursing staff involved in extended post anaesthetic care in PACU service, and evaluate the perceived usefulness, perceived ease of use, social influence of subjective norm, and perceived behavioral control of facilitating condition. A differential analysis would be conducted for the evaluation.

Study Design

Study Type:
Observational
Actual Enrollment :
299 participants
Observational Model:
Case-Control
Time Perspective:
Retrospective
Official Title:
The Rapid Conversion of Ordinary Recovery Beds to an Overnight Intensive Recovery (OIR) to Alleviate the High Pressure on Postoperative Intensive Care Demands During COVID-19 Pandemics in a Local Tertiary Hospital: a Multi-perspective Value-based Analysis
Actual Study Start Date :
Feb 10, 2020
Actual Primary Completion Date :
Feb 28, 2021
Actual Study Completion Date :
Jun 30, 2021

Arms and Interventions

Arm Intervention/Treatment
postoperative patients admitted to TMH extended post anaesthetic care in PACU

Exclusion criteria: Patients awaiting ICU admission in the ordinary recovery room Patients requiring level 3 intensive care on arrival at the recovery room

Other: overnight intensive recovery / extended post anaesthetic care in PACU
From January 2020, during COVID-19 first pandemics in Hong Kong, a bundle of interim measures was implemented with the joint efforts of the Department of Anaesthesia and Operating Theatre Services (A&OT) and Intensive Care Unit (ICU), and two ordinary recovery beds were converted into extended post anesthetic care in PACU (ExRR), based on the concept of overnight intensive recovery (OIR) to provide level 2 intensive care to patients undergoing major or ultra-major operations or having multiple comorbidities warranted intensive care in the immediately postoperative periods. This was conducted over 3 pandemic waves in Hong Kong.

Postoperative patient admitted to ICU with case matched

Inclusion criteria: o Based on case matched with the extended post anaesthetic care in PACU

Outcome Measures

Primary Outcome Measures

  1. total number of ICU bed days spared [during study period, up to 1 year]

Secondary Outcome Measures

  1. amount of healthcare expenditures based on bed occupancy and manpower [during study period, up to 1 year]

  2. number of unanticipated intensive care unit admission within 48 hours upon discharge to general ward [48 hour]

  3. rate of elective discharge to the intensive care unit [After extended post anaesthetic care in PACU service by case. Up to 24 hour]

  4. length of hospital stays [during admission or patient death, typically up to 1 month]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion criterion:

o Postoperative patients admitted to TMH Extended post anesthetic care in PACU during COVID-19 pandemics

Exclusion criteria:
  • Patients awaiting ICU admission in the ordinary recovery room

  • Patients requiring level 3 intensive care on arrival at the recovery room

Contacts and Locations

Locations

Site City State Country Postal Code
1 Operation Theatre, Tuen Mun Hospital Tuen Mun Hong Kong

Sponsors and Collaborators

  • Tuen Mun Hospital
  • Anaesthesia & Operation Theatre Service, Tuen Mun Hospital, Hong Kong
  • Intensive Care Unit, Tuen Mun Hospital, Hong Kong

Investigators

  • Study Director: Carmen Lam, Tuen Mun Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Lau Hon Wai, Medical Officer, Tuen Mun Hospital
ClinicalTrials.gov Identifier:
NCT04717089
Other Study ID Numbers:
  • TMH-ExRR-001
First Posted:
Jan 20, 2021
Last Update Posted:
Oct 6, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 6, 2021